|
[Related PubMed/MEDLINE]
Total Number of Papers: 137
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: LTRAs |
| Long Form |
: leukotriene receptor antagonists |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Montelukast Increased IL-25, IL-33, and TSLP via Epigenetic Regulation in Airway Epithelial Cells. |
IL, MAPK, NF-kappaB, TSLP |
| 2 |
2022 |
A Comparison of the Effectiveness of Asthma Medications on Asthma Exacerbations in Real World National Cohort. |
HR, ICSs, LABAs, LAMAs |
| 3 |
2022 |
Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study. |
aHR, CI, HRs, RCTs |
| 4 |
2022 |
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19. |
NERD, NSAIDs |
| 5 |
2022 |
Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma. |
CRS, CSS, CVA, FeNO, VAS |
| 6 |
2022 |
Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study. |
TS |
| 7 |
2022 |
Leukotriene Receptor Antagonists and Risk of Neuropsychiatric Entities: A Meta-Analysis of Observational Studies. |
AR, CI, NP, OR |
| 8 |
2022 |
Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series. |
AR, IRRs, NPEs, Obs2 |
| 9 |
2022 |
Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea. |
ICSs |
| 10 |
2022 |
The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan. |
--- |
| 11 |
2021 |
Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review. |
ADRs, CYP, RCT |
| 12 |
2021 |
Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland. |
ACQ, GETE, ICS, MiniAQLQ, OCS |
| 13 |
2021 |
Efficacy and safety of add-on tiotropium in the management of uncontrolled asthma: a patient case series. |
ICS |
| 14 |
2021 |
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia. |
AD, MCI |
| 15 |
2021 |
Leukotriene Receptor Antagonist Use and Dementia Risk in Patients With Asthma: A Retrospective Cohort Study. |
--- |
| 16 |
2021 |
Leukotrienes Are Dispensable for Vaginal Neutrophil Recruitment as Part of the Immunopathological Response During Experimental Vulvovaginal Candidiasis. |
LTs, PMNs, RVVC, VVC |
| 17 |
2021 |
Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence. |
AR, CI, MD, OR, QoL, RCTs, RQLQ, SAHs |
| 18 |
2021 |
Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines. |
CSU, CU, fgAHs, RCTs, sgAHs |
| 19 |
2021 |
Prescription rate and treatment patterns for allergic rhinitis from 2010 to 2018 in South Korea: a retrospective study. |
AR |
| 20 |
2021 |
The Addition of Montelukast for the Treatment of Chronic Idiopathic Urticaria. |
CU |
| 21 |
2020 |
A case-control study: Evaluating the role of leukotriene receptor antagonists in preventing the cardiovascular and cerebrovascular disease. |
IS, MI |
| 22 |
2020 |
A comparison of tiotropium, long-acting beta2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma. |
AEs, ICS, LABAs, LAMAs, RCTs |
| 23 |
2020 |
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. |
ICS, LABAs, LAMA |
| 24 |
2020 |
The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial. |
ACF, CRC, UMIN |
| 25 |
2019 |
A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma. |
ICSs |
| 26 |
2019 |
Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients. |
ANCA, EGPA |
| 27 |
2019 |
Influence of weight status in the response to Step-2 maintenance therapies in children with asthma. |
BMI, ICS, LRT, RERI |
| 28 |
2019 |
Management of paediatric obstructive sleep apnoea: A systematic review and network meta-analysis. |
AHI, ODI, OSA, RME |
| 29 |
2018 |
Association between dry eye disease and asthma: a nationwide population-based study. |
CI, DED, OR |
| 30 |
2018 |
Comparison of clinical characteristics and management of asthma by types of health care in South Korea. |
HIRA, PFT |
| 31 |
2018 |
Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest. |
Bax, Bcl-2 |
| 32 |
2018 |
Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis. |
CysLTR1, DDAH1, DEPs, KO, NO, PKCdelta, WB, WT |
| 33 |
2018 |
Leukotriene receptor antagonists for eczema. |
CI, EASI, SCORAD |
| 34 |
2018 |
Oral Antihistamines Alone vs in Combination with Leukotriene Receptor Antagonists for Allergic Rhinitis: A Meta-analysis. |
AR, CI, RCTs, WMD |
| 35 |
2017 |
Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. |
AMED, CENTRAL, CI, CINAHL, ICS, MD, NNTB, PEFR, RCTs, RR |
| 36 |
2017 |
Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma. |
CysLT1 |
| 37 |
2017 |
Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma. |
--- |
| 38 |
2017 |
The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. |
5-LO |
| 39 |
2016 |
Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies. |
CV, FFS, ICSs, LABAs, OR |
| 40 |
2016 |
Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients. |
--- |
| 41 |
2016 |
Leukotriene Receptor Antagonists and Antiallergy Drugs. |
AR, EIA, ICS, LABA, TXA2 |
| 42 |
2016 |
Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients. |
COPD, EA, ICS |
| 43 |
2015 |
Addition to inhaled corticosteroids of leukotriene receptor antagonists versus theophylline for symptomatic asthma: a meta-analysis. |
CI, ICSs, MD, PEF, RCTs |
| 44 |
2015 |
Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis. |
ICS, LABA |
| 45 |
2015 |
Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma. |
ALA-ACRC, GWAS, SNPs |
| 46 |
2015 |
Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children. |
EVW, OR |
| 47 |
2015 |
Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis. |
RR |
| 48 |
2015 |
Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children. |
--- |
| 49 |
2015 |
[A comparative study on efficiency of different therapeutics methods used for obstructive sleep apnea hypopnea syndrome in children]. |
AHI, MAT, MM, ODI, OSA-18, OSAHS, PSG, SAT, SM |
| 50 |
2014 |
New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy. |
CM, HE, OIT |
| 51 |
2014 |
Symptomatic treatment of the cough in whooping cough. |
CI, MD, RCTs |
| 52 |
2014 |
The changing face of severe childhood asthma: a comparison of two cohorts of children evaluated at National Jewish Health over the past 20 years. |
GCs, LABAs |
| 53 |
2014 |
The role of leukotriene receptor antagonists in exercise induced bronchoconstriction in children. |
EIB |
| 54 |
2014 |
[Discussion on the treatment methods of pediatric obstructive sleep apnea hypopnea syndrome]. |
OSAHS, PSG |
| 55 |
2013 |
A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation. |
--- |
| 56 |
2013 |
Comparative outcomes of leukotriene receptor antagonists and long-acting beta-agonists as add-on therapy in asthmatic patients: a population-based study. |
ICSs, ITT, LABAs |
| 57 |
2013 |
Cough, asthma, and cysteinyl-leukotrienes. |
CVA |
| 58 |
2013 |
Leukotriene receptor antagonists for small-airway abnormalities in asthmatics: a systematic review and meta-analysis. |
CI, ICSs, MD, SMD |
| 59 |
2013 |
Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis. |
AC |
| 60 |
2013 |
Leukotriene receptor antagonists pranlukast and montelukast for treating asthma. |
CysLTs, ICS |
| 61 |
2012 |
Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma. |
CI, ICSs, OR, OR, URI |
| 62 |
2012 |
Characterization of long-acting beta₂-adrenergic agonists utilization in asthma patients. |
FDA, FDC, ICS, LABAs, MCR, SI |
| 63 |
2012 |
Inhibition of common cold-induced aggravation of childhood asthma by leukotriene receptor antagonists. |
ACT, C-ACT |
| 64 |
2012 |
Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma. |
ICSs, MLK |
| 65 |
2012 |
Symptomatic treatment of the cough in whooping cough. |
CI, MD, RCTs |
| 66 |
2012 |
Update on leukotriene receptor antagonists in preschool children wheezing disorders. |
ICS, LTs |
| 67 |
2011 |
Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma. |
CVA, PG, VAS |
| 68 |
2011 |
Comparison of leukotriene receptor antagonists and anti-histamines as an add-on therapy in patients with asthma complicated by allergic rhinitis. |
--- |
| 69 |
2011 |
Delay of onset of symptoms of Japanese cedar pollinosis by treatment with a leukotriene receptor antagonist. |
--- |
| 70 |
2011 |
That ICS should be first line therapy for asthma--con. |
ICS |
| 71 |
2010 |
Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing. |
ICS |
| 72 |
2010 |
Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. |
--- |
| 73 |
2010 |
Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial. |
ICS |
| 74 |
2010 |
Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial. |
ACQ, beta2 agonists, ICS, MiniAQLQ |
| 75 |
2010 |
Effects of leukotriene receptor antagonists on peripheral eosinophil counts and serum IgE levels in children with food allergy. |
ECP, IL |
| 76 |
2010 |
Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics. |
AIA |
| 77 |
2010 |
Symptomatic treatment of the cough in whooping cough. |
CENTRAL, CI, DARE, RCTs |
| 78 |
2010 |
[The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome]. |
CSS |
| 79 |
2009 |
Churg Strauss Syndrome after polypectomy in asthmatic and allergic patients. |
CSS |
| 80 |
2009 |
Development of Churg-Strauss syndrome with severe multiple mononeuropathy after leukotriene receptor antagonist treatment in one of the monozygotic twins with asthma: case report. |
CSS |
| 81 |
2009 |
Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options. |
EIB, EL, GR, ICSs, RCTs |
| 82 |
2009 |
Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study. |
FEX |
| 83 |
2009 |
[Efficacy of leukotriene receptor antagonists in asthma treatment and analysis of background factors evaluated by a questionnaire survey among physicians]. |
--- |
| 84 |
2008 |
Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma? |
FSH, IS, LH, PEFR, PFT, PMA |
| 85 |
2008 |
The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction? |
CSS |
| 86 |
2007 |
Antileukotriene drugs: clinical application, effectiveness and safety. |
5-LO, CysLTs |
| 87 |
2007 |
Antileukotrienes as adjunctive therapy in acute asthma. |
--- |
| 88 |
2007 |
Churg Strauss syndrome after introducing oral steroid to inhaler: a report of three cases. |
--- |
| 89 |
2007 |
Clinical evaluation of leukotriene receptor antagonists in preventing common cold-like symptoms in bronchial asthma patients. |
ICS |
| 90 |
2007 |
Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. |
FeNO |
| 91 |
2007 |
Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA). |
CysLTR1, EIA, EIB, FEV1, LTC4S |
| 92 |
2007 |
Safety of leukotriene receptor antagonists in pregnancy. |
--- |
| 93 |
2007 |
Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers. |
ALOX5, CysLTR1, CysLTs, ICS, LT, LTA4H, LTC4S, MRP1 |
| 94 |
2006 |
Asthma control in Switzerland: a general practitioner based survey. |
ACQ, GINA, ICS |
| 95 |
2006 |
Asthma mortality in portugal : impact of treatment with inhaled corticosteroids and leukotriene receptor antagonists. |
DDDs |
| 96 |
2006 |
Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities. |
CysLTRs |
| 97 |
2006 |
Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. |
LT |
| 98 |
2006 |
Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma. |
IFN-gamma, IL-5, RLRIs, RSV |
| 99 |
2006 |
Effects of leukotriene receptor antagonists on monocyte chemotaxis, p38 and cytoplasmic calcium. |
CBMCs, MCP-1, PBMCs |
| 100 |
2006 |
Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. |
AR, ECP, NAR, PAR, PRQLQ, TSS |
|
A Search Service for Abbreviation / Long Form
